Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Centessa Pharmaceuticals PLC Sponsored ADR (CNTA) had Debt to Equity Ratio of 0.23 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-79.24M |
|
-- |
|
-- |
|
$79.77M |
|
$-79.77M |
|
$1.38M |
|
$-78.39M |
|
$-78.39M |
|
$-79.24M |
|
$-79.24M |
|
$-79.24M |
|
$-79.24M |
|
$-79.77M |
|
$-79.19M |
|
153.55M |
|
153.55M |
|
$-0.52 |
|
$-0.52 |
|
| Balance Sheet Financials | |
$348.68M |
|
$0.72M |
|
$293.08M |
|
$641.76M |
|
$36.57M |
|
$110.44M |
|
$117.84M |
|
$154.41M |
|
$487.35M |
|
$487.35M |
|
$487.35M |
|
154.73M |
|
| Cash Flow Statement Financials | |
$-72.22M |
|
$42.71M |
|
$30.47M |
|
$61.95M |
|
$63.09M |
|
$1.13M |
|
$10.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.53 |
|
-- |
|
-- |
|
0.18 |
|
|
Debt to Equity Ratio |
0.23 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-72.22M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-16.26% |
|
-16.26% |
|
-12.35% |
|
-13.26% |
|
$3.15 |
|
$-0.47 |
|
$-0.47 |
|